Exelixis Inc (NAS:EXEL)
$ 36.115 0.265 (0.74%) Market Cap: 10.31 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.15 PB Ratio: 4.54 GF Score: 91/100

Exelixis Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 08:40PM GMT
Release Date Price: $24.88 (-3.15%)
Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Hello, and welcome to the UBS Global Healthcare Conference. We're having one of the last sessions this afternoon. My next -- my name is Navin Jacob, senior analyst covering large-cap pharmaceuticals and smid cap biotech.

Our next presentation fireside chat is with Exelixis and Michael Morrissey, the CEO. I'm so happy to have him with us today. Mike, thank you for joining us today. I hope you're well.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

I am. Thanks for the invite and the opportunity to participate in your virtual meeting for sure. It's great so far.

Navin Cyriac Jacob
UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic

Yes. No -- well, speaking of virtual meetings, what's caused us to get into this situation obviously can't be ignored: COVID-19. Maybe we can just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot